BARDA
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
Top Five Articles on 360Dx Last Week: Siemens Healthineers Dx Changes; Job Cuts at Sema4; and More
Last week, readers were most interested in Siemens Healtineers' plans to trim its diagnostics portfolio.
Hologic Secures $19M BARDA Contract for COVID-19, Combination Assays
The money will support research and development to help the company gain FDA approval for its SARS-CoV-2 test and a SARS-CoV-2, influenza A and B, and RSV test.
POC Dx Firm Senzo Nabs $750K Contract From BARDA for COVID-19 Test
The funding is intended to help Senzo garner Emergency Use Authorization for its Amplified Lateral Flow COVID-19 test.
DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument
The Italian firm said the Liaison NES will help improve access to testing for bacterial and viral diseases through an easy-to-use instrument running lower cost assays.